Giuseppe Leone: The Evolving Treatment Landscape of Adult ITP
Giuseppe Leone, Editor in Chief on Mediterranean Journal of Hematology and Infectious Diseases, Faculty of Medicine, Università Cattolica, shared a post on LinkedIn about a recent article by Massimo Martino et al., published in Mediterranean Journal of Hematology and Infectious Diseases, adding:
“For decades, treatment relied on corticosteroids as first-line therapy, followed by a limited range of second-line options including thrombopoietin receptor agonists (TPO-RAs), rituximab, splenectomy, and, more recently, fostamatinib.
Growing understanding of the immune mechanisms underlying both accelerated platelet destruction and impaired platelet production has expanded the therapeutic landscape. and in the last few years new dugs have been introduced.
This narrative review, free online in the MJHID, focuses on primary ITP in adults and summarizes current evidence on epidemiology, pathophysiology, clinical and humanistic burden, established therapies, and emerging targeted treatments.”
Title: Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Biologic Therapies
Authors: Massimo Martino, Laura Giordano, Maria Bruna Greve, Violetta Marafioti, Caterina Alati

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 14:25Sameer A.: When Heparin Triggers Thrombosis – A Case of HIT
-
Nov 20, 2026, 14:21Chris Oung: Postoperative VTE Risk and Timing Across Surgical Specialties
-
Nov 20, 2026, 14:17Melissa Pickett: HIT Detection Can Miss a Critical Platelet Decline
-
Nov 20, 2026, 14:02Hasan Burak İşleyen։ Thrombocytopenia and Mortality in Critically Ill Cancer Patients
-
Nov 20, 2026, 13:50Louise Maes: CONVINCE Trial Imaging Studies Reveal New Insights Into Carotid Plaque and Vascular Risk
-
Nov 20, 2026, 13:50Lara Kurdi: A Presentation of Triple-Positive Antiphospholipid Syndrome
-
Nov 20, 2026, 13:46Rahul Bohra: Beyond Platelet Counts – The Lived Experience of ITP
-
Nov 20, 2026, 13:34Yohei Hisada: How Well Do Mouse Leukemia Models Reflect Human Disease?
-
Nov 20, 2026, 13:20Ilenia Calcaterra: The Inferior Thyroid Arteries as a Window Into Cardiovascular Risk